vs
安捷伦科技（A）与Evercore Inc.（EVR）财务数据对比。点击上方公司名可切换其他公司
安捷伦科技的季度营收约是Evercore Inc.的1.4倍（$1.8B vs $1.3B），安捷伦科技净利率更高（17.0% vs 15.7%，领先1.2%），Evercore Inc.同比增速更快（32.4% vs 7.0%），Evercore Inc.自由现金流更多（$798.6M vs $175.0M），过去两年Evercore Inc.的营收复合增速更高（48.9% vs 6.9%）
安捷伦科技是全球知名的生命科学、诊断与应用化学领域解决方案提供商，旗下生命科学与应用市场业务板块提供液相色谱系统及组件、液相色谱质谱联用系统、气相色谱设备、电感耦合等离子体质谱仪、原子吸收仪等多种分析检测仪器，服务全球各领域客户。
Evercore Inc.（前称Evercore Partners）是1995年由罗杰·奥尔特曼、大卫·奥芬森德、奥斯汀·博伊特纳联合创立的全球独立投资银行咨询机构。成立至今，公司已为总规模超4.7万亿美元的并购、重组交易提供专业咨询服务，在全球投行业务领域拥有较高声誉。
A vs EVR — 直观对比
营收规模更大
A
是对方的1.4倍
$1.3B
营收增速更快
EVR
高出25.5%
7.0%
净利率更高
A
高出1.2%
15.7%
自由现金流更多
EVR
多$623.6M
$175.0M
两年增速更快
EVR
近两年复合增速
6.9%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.8B | $1.3B |
| 净利润 | $305.0M | $204.0M |
| 毛利率 | 52.6% | — |
| 营业利润率 | 19.6% | 24.2% |
| 净利率 | 17.0% | 15.7% |
| 营收同比 | 7.0% | 32.4% |
| 净利润同比 | -4.1% | 45.2% |
| 每股收益（稀释后） | $1.07 | $4.80 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AEVR
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.9B | $1.3B | ||
| Q3 25 | $1.7B | $1.0B | ||
| Q2 25 | $1.7B | $838.0M | ||
| Q1 25 | $1.7B | $699.0M | ||
| Q4 24 | $1.7B | $979.5M | ||
| Q3 24 | $1.6B | $738.4M | ||
| Q2 24 | $1.6B | $693.4M |
净利润AEVR
| Q1 26 | $305.0M | — | ||
| Q4 25 | $434.0M | $204.0M | ||
| Q3 25 | $336.0M | $144.6M | ||
| Q2 25 | $215.0M | $97.2M | ||
| Q1 25 | $318.0M | $146.2M | ||
| Q4 24 | $351.0M | $140.4M | ||
| Q3 24 | $282.0M | $78.4M | ||
| Q2 24 | $308.0M | $73.8M |
毛利率AEVR
| Q1 26 | 52.6% | — | ||
| Q4 25 | 53.2% | — | ||
| Q3 25 | 51.1% | — | ||
| Q2 25 | 51.9% | — | ||
| Q1 25 | 53.5% | — | ||
| Q4 24 | 53.9% | — | ||
| Q3 24 | 54.2% | — | ||
| Q2 24 | 54.4% | — |
营业利润率AEVR
| Q1 26 | 19.6% | — | ||
| Q4 25 | 23.8% | 24.2% | ||
| Q3 25 | 20.7% | 20.8% | ||
| Q2 25 | 18.0% | 18.0% | ||
| Q1 25 | 22.4% | 16.0% | ||
| Q4 24 | 24.0% | 21.8% | ||
| Q3 24 | 21.1% | 16.7% | ||
| Q2 24 | 23.1% | 15.9% |
净利率AEVR
| Q1 26 | 17.0% | — | ||
| Q4 25 | 23.3% | 15.7% | ||
| Q3 25 | 19.3% | 13.8% | ||
| Q2 25 | 12.9% | 11.6% | ||
| Q1 25 | 18.9% | 20.9% | ||
| Q4 24 | 20.6% | 14.3% | ||
| Q3 24 | 17.9% | 10.6% | ||
| Q2 24 | 19.6% | 10.6% |
每股收益（稀释后）AEVR
| Q1 26 | $1.07 | — | ||
| Q4 25 | $1.53 | $4.80 | ||
| Q3 25 | $1.18 | $3.41 | ||
| Q2 25 | $0.75 | $2.36 | ||
| Q1 25 | $1.11 | $3.48 | ||
| Q4 24 | $1.23 | $3.32 | ||
| Q3 24 | $0.97 | $1.86 | ||
| Q2 24 | $1.05 | $1.81 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.8B | $3.0B |
| 总债务越低越好 | $3.0B | — |
| 股东权益账面价值 | $6.9B | $2.0B |
| 总资产 | $12.8B | $5.4B |
| 负债/权益比越低杠杆越低 | 0.44× | — |
8季度趋势，按日历期对齐
现金及短期投资AEVR
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | $3.0B | ||
| Q3 25 | $1.5B | $2.4B | ||
| Q2 25 | $1.5B | $1.7B | ||
| Q1 25 | $1.5B | $1.4B | ||
| Q4 24 | $1.3B | $2.4B | ||
| Q3 24 | $1.8B | $1.8B | ||
| Q2 24 | $1.7B | $1.7B |
总债务AEVR
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | — | ||
| Q3 25 | $3.4B | — | ||
| Q2 25 | $3.3B | — | ||
| Q1 25 | $3.3B | — | ||
| Q4 24 | $3.3B | — | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.1B | — |
股东权益AEVR
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.7B | $2.0B | ||
| Q3 25 | $6.4B | $1.8B | ||
| Q2 25 | $6.1B | $1.7B | ||
| Q1 25 | $6.0B | $1.5B | ||
| Q4 24 | $5.9B | $1.7B | ||
| Q3 24 | $5.9B | $1.6B | ||
| Q2 24 | $6.2B | $1.5B |
总资产AEVR
| Q1 26 | $12.8B | — | ||
| Q4 25 | $12.7B | $5.4B | ||
| Q3 25 | $12.2B | $4.4B | ||
| Q2 25 | $12.2B | $3.7B | ||
| Q1 25 | $11.9B | $3.3B | ||
| Q4 24 | $11.8B | $4.2B | ||
| Q3 24 | $11.0B | $3.6B | ||
| Q2 24 | $10.9B | $3.3B |
负债/权益比AEVR
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.45× | — | ||
| Q3 25 | 0.53× | — | ||
| Q2 25 | 0.55× | — | ||
| Q1 25 | 0.56× | — | ||
| Q4 24 | 0.57× | — | ||
| Q3 24 | 0.36× | — | ||
| Q2 24 | 0.34× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $268.0M | $807.5M |
| 自由现金流经营现金流 - 资本支出 | $175.0M | $798.6M |
| 自由现金流率自由现金流/营收 | 9.7% | 61.6% |
| 资本支出强度资本支出/营收 | 5.2% | 0.7% |
| 现金转化率经营现金流/净利润 | 0.88× | 3.96× |
| 过去12个月自由现金流最近4个季度 | $993.0M | $1.2B |
8季度趋势，按日历期对齐
经营现金流AEVR
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $807.5M | ||
| Q3 25 | $362.0M | $560.9M | ||
| Q2 25 | $221.0M | $437.7M | ||
| Q1 25 | $431.0M | $-549.7M | ||
| Q4 24 | $481.0M | $686.4M | ||
| Q3 24 | $452.0M | $234.5M | ||
| Q2 24 | $333.0M | $348.5M |
自由现金流AEVR
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | $798.6M | ||
| Q3 25 | $259.0M | $541.5M | ||
| Q2 25 | $107.0M | $411.7M | ||
| Q1 25 | $334.0M | $-569.3M | ||
| Q4 24 | $388.0M | $673.1M | ||
| Q3 24 | $360.0M | $226.6M | ||
| Q2 24 | $230.0M | $340.7M |
自由现金流率AEVR
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | 61.6% | ||
| Q3 25 | 14.9% | 51.8% | ||
| Q2 25 | 6.4% | 49.1% | ||
| Q1 25 | 19.9% | -81.4% | ||
| Q4 24 | 22.8% | 68.7% | ||
| Q3 24 | 22.8% | 30.7% | ||
| Q2 24 | 14.6% | 49.1% |
资本支出强度AEVR
| Q1 26 | 5.2% | — | ||
| Q4 25 | 5.0% | 0.7% | ||
| Q3 25 | 5.9% | 1.9% | ||
| Q2 25 | 6.8% | 3.1% | ||
| Q1 25 | 5.8% | 2.8% | ||
| Q4 24 | 5.5% | 1.4% | ||
| Q3 24 | 5.8% | 1.1% | ||
| Q2 24 | 6.5% | 1.1% |
现金转化率AEVR
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | 3.96× | ||
| Q3 25 | 1.08× | 3.88× | ||
| Q2 25 | 1.03× | 4.50× | ||
| Q1 25 | 1.36× | -3.76× | ||
| Q4 24 | 1.37× | 4.89× | ||
| Q3 24 | 1.60× | 2.99× | ||
| Q2 24 | 1.08× | 4.72× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
EVR
| Advisory Fees | $1.1B | 87% |
| Commissions And Related Revenue | $66.5M | 5% |
| Underwriting Fees | $49.5M | 4% |
| Other | $29.6M | 2% |
| Investment Management | $23.2M | 2% |
